InfuSystem Holdings (INFU) Accounts Payables (2010 - 2026)
InfuSystem Holdings' (INFU) quarterly Accounts Payables came in at $9.6 million in Q1 2026, up 15.12% YoY from $8.4 million in Q1 2025, and down 10.99% on a QoQ basis from $10.8 million in Q4 2025.
InfuSystem Holdings (INFU) Accounts Payables (2010 - 2026) Analysis & Trends
InfuSystem Holdings (INFU) has 17 years of Accounts Payables data on file, last reported at $9.6 million in Q1 2026.
- Quarterly Accounts Payables rose 15.12% year-over-year to $9.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.6 million (up 15.12% YoY) and the FY2025 annual result came in at $10.8 million, up 9.88% from the prior year.
- Accounts Payables retreated to $9.6 million in Q1 2026, from $10.8 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $10.8 million in Q4 2025 to a low of $5.5 million in Q2 2023.
- A 5-year average of $8.7 million and a median of $8.9 million in 2024 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2023 — Accounts Payables tumbled 41.9% — and 2024, when it soared 81.35%.
- Tracing INFU's Accounts Payables over 5 years: stood at $8.3 million in 2022, then fell by 3.98% to $8.0 million in 2023, then advanced by 22.96% to $9.8 million in 2024, then advanced by 9.88% to $10.8 million in 2025, then decreased by 10.99% to $9.6 million in 2026.
- The last three Accounts Payables figures came in at $9.6 million (Q1 2026), $10.8 million (Q4 2025), and $10.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 4.79 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 2.64 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1.23 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 210.50 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 3.23 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 2.42 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 344.10 Mn |
| 10 | InfuSystem Holdings | 244.67 Mn | 243.70 Mn | 21.41 Mn | 8.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.98 Mn |
| Mar 31, 2026 | 9.63 Mn |
| Dec 31, 2025 | 10.82 Mn |
| Sep 30, 2025 | 10.02 Mn |
| Jun 30, 2025 | 9.32 Mn |
| Mar 31, 2025 | 8.37 Mn |
| Dec 31, 2024 | 9.85 Mn |
| Sep 30, 2024 | 8.91 Mn |
| Jun 30, 2024 | 9.94 Mn |
| Mar 31, 2024 | 9.80 Mn |
| Dec 31, 2023 | 8.01 Mn |
| Sep 30, 2023 | 7.63 Mn |
| Jun 30, 2023 | 5.48 Mn |
| Mar 31, 2023 | 7.37 Mn |
| Dec 31, 2022 | 8.34 Mn |
| Sep 30, 2022 | 6.65 Mn |
| Jun 30, 2022 | 9.43 Mn |
| Mar 31, 2022 | 8.24 Mn |
| Dec 31, 2021 | 7.86 Mn |
| Sep 30, 2021 | 6.70 Mn |